The report noted that innovative measures currently being tried in India like establishing satellite vaccination centres closer to hamlets in rural settings and resident welfare associations in urban areas; converting community halls and using large parking spaces for drive-in vaccination; and using mobile vaccination facilities to cover populations that do not live within easy access of vaccination centres.
Category:
Pandemic
Latest
Final analysis of Covaxin efficacy out; vaccine 65.2 percent effective against Delta variant
Director-General of ICMR, Balram Bhargava said, ”I am delighted to note that Covaxin developed by ICMR and BBIL under an effective public private partnership, has demonstrated an overall efficacy of 77.8 percent in Indias largest COVID phase 3 clinical trial thus far.
He further said Covaxin will not only benefit the Indian citizens but would also immensely contribute to protecting the global community against the deadly SARS-CoV-2 virus.
Dr Reddy’s denied approval for Phase 3 trials of Sputnik Light vaccine
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.